Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872016 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusions: Induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with etoposide and cisplatin showed very promising survival in patients with Stage III NSCLC, especially in those without supraclavicular nodal involvement, which warrants further evaluation.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Dae Ho M.D., Ji-Youn M.D., Kwan Ho M.D., Hong Ryull M.D., Hyae Young M.D., Sung Jin B.S., Jin Soo M.D.,